Pfizer Inc. ( PFE) - Key Metrics
PFE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $2.91 | $0.57 | $0.94 | $0.84 |
| 2026Q2 | $2.64 | -$0.04 | $0.15 | $0.05 |
| 2026Q1 | $2.54 | $0.47 | $0.46 | $0.38 |
| 2025Q4 | $3.09 | -$0.29 | $0.94 | $0.79 |
| 2025Q3 | $2.93 | $0.62 | $0.81 | $0.70 |
PFE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 75.60% | 12.60 |
| 2026Q2 | -988.31% | -141.03 |
| 2026Q1 | 90.99% | 14.77 |
| 2025Q4 | -148.36% | -21.47 |
| 2025Q3 | 69.02% | 9.62 |
PFE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 2.93% | 1.50% |
| 2026Q2 | 0.22% | 1.76% |
| 2026Q1 | 1.38% | 1.55% |
| 2025Q4 | 3.18% | 1.73% |
| 2025Q3 | 2.95% | 1.80% |
PFE
Price: $27.52
Dividend Yield: 7.32%
Forward Dividend Yield: 6.25%
Payout Ratio: -365.22%
Dividend Per Share: 1.72 USD
Earnings Per Share: 0.70 USD
P/E Ratio: 41.76
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 23.8 million
Ebitda: 3.6 billionMarket Capitalization: 166.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 55
DGR3: 2.44%
DGR5: 2.50%
DGR10: 4.40%
DGR20: 5.01%